Cite
HARVARD Citation
Zomorodi, K. et al. (2019). Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis. Journal of clinical pharmacology. pp. 1120-1129. [Online].